Collectively, our data established tumor-intrinsic STAT3 signaling as a rate-limiting gatekeeper function for KPT tumors and suggest that the acquisition of Trp53 mutations induces a switch from IL-11 dependency to IL-6 dependency. This evidence concerns the gene IL11 and neoplasm.